Development and performance of a fully automated method for assay of C-reactive protein in the aca discrete clinical analyzer

11Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A quantitative immunoassay for C-reactive protein (CRP) has been developed for use in the Du Pont aca discrete clinical analyzer. Particle-enhanced turbidimetric immunoassay (PETIA) technology is used. The method has a CV of <10% in the range 2 to 120 mg/L. Neither hemolyzed samples (Hb <5 g/L), icteric samples (total bilirubin <300 mg/L), lipemic samples (triglyceride <15 g/L), nor some commonly used drugs interfere. Dithioerythritol is used to eliminate interference from rheumatoid factor. Good correlation was seen when the Du Pont CRP method was compared with the Beckman ICS, Syva EMIT, TDx, and Behring methods for CRP. The normal reference interval is 0 to 9 mg/L. The method, which is fully automated, is fast, requires only a few microliters of serum, and is well suited to emergency-room requirements.

Cite

CITATION STYLE

APA

Schwartz, M. W., Schifreen, R. S., Gorman, E., Tuhy, P. M., Bienvenu, J., & Warkentin, D. L. (1988). Development and performance of a fully automated method for assay of C-reactive protein in the aca discrete clinical analyzer. Clinical Chemistry, 34(8), 1646–1649. https://doi.org/10.1093/clinchem/34.8.1646

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free